ATE356358T1 - Verfahren zur auswertung des knorpelgewebeabbau - Google Patents

Verfahren zur auswertung des knorpelgewebeabbau

Info

Publication number
ATE356358T1
ATE356358T1 AT05356011T AT05356011T ATE356358T1 AT E356358 T1 ATE356358 T1 AT E356358T1 AT 05356011 T AT05356011 T AT 05356011T AT 05356011 T AT05356011 T AT 05356011T AT E356358 T1 ATE356358 T1 AT E356358T1
Authority
AT
Austria
Prior art keywords
degradation
evaluation
sequence seq
type
tissue degradation
Prior art date
Application number
AT05356011T
Other languages
English (en)
Inventor
Patrick Garnero
Nadine Charni
Original Assignee
Synarc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synarc filed Critical Synarc
Application granted granted Critical
Publication of ATE356358T1 publication Critical patent/ATE356358T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05356011T 2004-01-14 2005-01-14 Verfahren zur auswertung des knorpelgewebeabbau ATE356358T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0400292A FR2865034A1 (fr) 2004-01-14 2004-01-14 Procede d'evaluation de la degradation du tissu cartilagineux d'un individu

Publications (1)

Publication Number Publication Date
ATE356358T1 true ATE356358T1 (de) 2007-03-15

Family

ID=34610766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05356011T ATE356358T1 (de) 2004-01-14 2005-01-14 Verfahren zur auswertung des knorpelgewebeabbau

Country Status (5)

Country Link
EP (1) EP1555531B1 (de)
AT (1) ATE356358T1 (de)
DE (1) DE602005000636T2 (de)
DK (1) DK1555531T3 (de)
FR (1) FR2865034A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109813911A (zh) * 2017-11-22 2019-05-28 江阴贝瑞森生化技术有限公司 一种可定量可追踪的测定贻贝粘蛋白降解的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
GB9702252D0 (en) * 1997-02-06 1997-03-26 Univ Sheffield Medical The Sch Collagen assay
US6642007B1 (en) * 1998-11-02 2003-11-04 Pfizer Inc. Assays for measurement of type II collagen fragments in urine

Also Published As

Publication number Publication date
EP1555531B1 (de) 2007-03-07
DE602005000636T2 (de) 2007-12-06
EP1555531A1 (de) 2005-07-20
FR2865034A1 (fr) 2005-07-15
DE602005000636D1 (de) 2007-04-19
DK1555531T3 (da) 2007-06-11

Similar Documents

Publication Publication Date Title
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
ES2570334T3 (es) Remodelado superficial de proteínas
ATE321849T1 (de) Verfahren zur erkennung von nucleinsäuremolekülen codierend für (poly)peptide, welche mit zielmolekülen interagieren
Mighell et al. Human tenascin‐C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae
EP1901063A3 (de) Verfahren zum Isolieren und/oder Identifizieren mesenchymaler Stammzellen
ATE465241T1 (de) Verfahren zur fermentativen herstellung von proteinen
BR9915732A (pt) Geração de anticorpos usando-se vacinação de polinucleotìdeo em espécie de ave
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2005124341A3 (en) Stable isotope labeled polypeptide standards for protein quantitation
EP1548107A4 (de) Chromoprotein und fluoroproteine
ATE356358T1 (de) Verfahren zur auswertung des knorpelgewebeabbau
ATE532793T1 (de) Verfahren zur herstellung von molekülen mit verminderter immunogenität
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
IL173969A0 (en) Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock
DE602005026525D1 (de) Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp-neoepitopen
ATE339500T1 (de) Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert
EP1580265A4 (de) Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren
EP1602721A4 (de) Aus koji-schimmelpilz stammende phospholipase a2
ATE403873T1 (de) Verfahren zur überwachung der typ-ii- kollagenabbau in knorpeln
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
EA200501508A1 (ru) Семейство секретируемых белков
WO2007123462A8 (en) A protein, an antibody and measurement of the protein
CY1116673T1 (el) Θραυσματα πεπτιδιου για την επαγωγη συνθεσης πρωτεϊνων εξωκυτταριας θεμελιας ουσιας
DE602006004966D1 (de) Intrinsic-faktor vom schwein
WO2009014160A1 (ja) 膵癌の新規腫瘍マーカー

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties